Exagen, Inc. (XGN)
8.17
+0.28
(+3.55%)
USD |
NASDAQ |
Oct 02, 16:00
8.14
-0.03
(-0.37%)
After-Hours: 20:00
Exagen Profit Margin (Quarterly) : -16.03% for June 30, 2026
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -16.03% |
| March 31, 2026 | -22.92% |
| December 31, 2025 | -28.10% |
| September 30, 2025 | -41.10% |
| June 30, 2025 | -25.81% |
| March 31, 2025 | -24.21% |
| December 31, 2024 | -27.54% |
| September 30, 2024 | -40.20% |
| June 30, 2024 | -19.69% |
| March 31, 2024 | -23.31% |
| December 31, 2023 | -40.49% |
| September 30, 2023 | -40.36% |
| June 30, 2023 | -35.46% |
| March 31, 2023 | -68.46% |
| December 31, 2022 | -111.8% |
| September 30, 2022 | -54.98% |
| June 30, 2022 | -192.8% |
| March 31, 2022 | -98.83% |
| December 31, 2021 | -55.58% |
| September 30, 2021 | -58.60% |
| June 30, 2021 | -50.19% |
| March 31, 2021 | -58.65% |
| December 31, 2020 | -27.26% |
| Date | Value |
|---|---|
| September 30, 2020 | -39.98% |
| June 30, 2020 | -37.58% |
| March 31, 2020 | -58.04% |
| December 31, 2019 | -33.37% |
| September 30, 2019 | -160.4% |
| June 30, 2019 | -26.59% |
| March 31, 2019 | -29.20% |
| December 31, 2018 | -13.66% |
| September 30, 2018 | -21.35% |
| June 30, 2018 | -27.58% |
| March 31, 2018 | -58.06% |
| December 31, 2015 | -56.93% |
| September 30, 2015 | -75.24% |
| June 30, 2015 | -216.7% |
| March 31, 2015 | -79.17% |
| December 31, 2014 | -30.75% |
| September 30, 2014 | -131.1% |
| June 30, 2014 | -169.4% |
| March 31, 2014 | -255.5% |
| December 31, 2013 | -590.8% |
| September 30, 2013 | -260.2% |
| June 30, 2013 | -349.5% |
| March 31, 2013 | -629.5% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Myriad Genetics, Inc. | -22.65% |
| BioRestorative Therapies, Inc. | -9.29K% |
| CareDx, Inc. | 83.85% |
| Natera, Inc. | -8.90% |
| Sera Prognostics, Inc. | -30.46K% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -113.6% |
| Return on Assets | -33.24% |
| Return on Invested Capital | -43.18% |
| Gross Profit Margin (Quarterly) | 61.27% |
| Operating Margin (Quarterly) | -8.64% |
| Return on Net Operating Assets | -70.08% |